12.1 Psychosocial Assessment & Distress Screening in Oncology
Key Takeaways
The NCCN Distress Thermometer (DT) is a validated 0–10 self-report screening tool paired with a 39-item Problem List; a cutoff score of ≥4 indicates clinically significant distress requiring immediate interdisciplinary evaluation.
Routine distress screening is mandated by the Commission on Cancer (CoC) and NCCN at critical transitional points: initial diagnosis, initiation of new treatment, disease recurrence, and transition to survivorship or end-of-life care.
Validated diagnostic and mood screening tools include the Patient Health Questionnaire-9 (PHQ-9) for depression (score ≥10 indicates moderate-to-severe depression) and the Generalized Anxiety Disorder-7 (GAD-7) scale for anxiety disorders.
Accurate differential diagnosis between major depressive disorder, adjustment disorder with depressed mood, cancer-related fatigue, and hypoactive delirium is essential to prevent psychiatric mislabeling and ensure targeted interventions.
Urgent psychiatric crisis evaluation and safety protocols must be initiated immediately for patients demonstrating active suicidal ideation, severe post-traumatic stress reactions, or acute organic psychosis.
Psychosocial Assessment & Distress Screening in Oncology
Psychosocial distress is an unpleasant experience of a mental, physical, social, or spiritual nature that impacts an individual's ability to cope effectively with cancer, its physical symptoms, and its treatment. Psychological distress exists along a continuum, ranging from common normal feelings of vulnerability, sadness, and fear to disabling psychiatric conditions such as major depressive disorder, severe generalized anxiety, panic disorder, and existential crisis. Approximately 35% to 45% of oncology patients experience clinically significant distress during their cancer continuum. For Advanced Practice Registered Nurses (APRNs), implementing systematic, evidence-based distress screening protocols and managing psychiatric comorbidities are essential to optimizing quality of life, treatment adherence, and overall survival.
1. NCCN Distress Thermometer & Problem List
The National Comprehensive Cancer Network (NCCN) established distress as the "6th vital sign" in oncology care. The NCCN Distress Thermometer (DT) is a validated, rapid self-report screening tool featuring a visual analog scale ranging from 0 ("No distress") to 10 ("Extreme distress").
Structure of the NCCN Distress Tool
- Distress Thermometer Rating: The patient reports their overall level of distress experienced over the past 7 days on the 0–10 scale.
- The 39-Item Problem List: Accompanies the thermometer, allowing patients to identify specific sources of distress across five primary domains:
- Practical Problems: Housing, insurance/financial, transportation, childcare, work/school.
- Family Problems: Dealing with partner/children, ability to have children, family health issues.
- Emotional Problems: Worry, sadness, anxiety, fear, loss of interest in usual activities, spiritual/existential distress.
- Spiritual/Religious Concerns: Loss of faith, crisis of meaning, conflict with religious beliefs.
- Physical Problems: Pain, fatigue, nausea, sleep disturbances, memory/concentration, mobility, bowel/bladder changes.
Clinical Cutoff Scores & Triage
- DT Score 0 to 3 (Mild Distress): Managed with primary oncology team support, psychoeducation, and routine re-screening.
- DT Score ≥4 (Clinically Significant Distress): Represents the evidence-based threshold for mandatory clinical evaluation and targeted interdisciplinary referral. A score of 4 or higher correlates with substantial functional impairment, reduced treatment compliance, and psychiatric co-morbidity.
2. Screening Frequency & Regulatory Standards
The Commission on Cancer (CoC) of the American College of Surgeons (Standard 5.2) mandates that accredited cancer centers perform routine, documented distress screening for oncology patients using a validated tool.
Key Transitional Screening Intervals
Psychosocial distress fluctuates dramatically across the disease trajectory. Screening must be performed at minimum during these critical clinical transition points:
- Initial Diagnosis: Baseline assessment prior to treatment initiation.
- Treatment Transitions: Start of chemotherapy, radiation therapy, or surgical intervention; switching treatment regimens due to disease progression or toxicity.
- End of Primary Treatment: Transition into post-treatment survivorship care.
- Disease Recurrence / Metastatic Progression: Re-evaluating psychological coping when treatment intent shifts to palliative care.
- Surveillances & Follow-Up: Routine intervals (e.g., every 3 to 6 months) during ongoing therapy or survivorship.
3. Validated Psychosocial & Mood Assessment Tools
When the initial DT score is elevated (≥4) or emotional concerns are identified, the APRN should administer targeted, validated diagnostic screening instruments:
| Screening Tool | Target Domain | Items & Scoring | Clinical Cutoff & Action |
|---|---|---|---|
| NCCN Distress Thermometer (DT) | Global Psychosocial Distress | 1 visual analog item (0–10) + 39-item Problem List | Score ≥4: Triggers mandatory interdisciplinary referral matching problem list. |
| Patient Health Questionnaire-9 (PHQ-9) | Depressive Symptoms & Severity | 9 items scored 0–3 (Total score 0–27) | 0–4: Minimal; 5–9: Mild; 10–14: Moderate; 15–19: Moderately severe; ≥20: Severe. Score ≥10 warrants psychiatric/pharmacologic intervention. Item 9 assesses self-harm. |
| Generalized Anxiety Disorder-7 (GAD-7) | Anxiety Symptom Severity | 7 items scored 0–3 (Total score 0–21) | 5–9: Mild; 10–14: Moderate; ≥15: Severe anxiety. Score ≥10 indicates probable GAD; triggers psychiatric referral or pharmacotherapy. |
| Hospital Anxiety and Depression Scale (HADS) | Anxiety & Depression in Medically Ill | 14 items (7 Anxiety, 7 Depression) excluding somatic complaints | 8–10: Doubtful case; ≥11: Definite clinical case for anxiety or depression subscale. Ignores somatic symptoms (fatigue, weight loss) caused by cancer. |
4. Differential Diagnosis of Mood & Cognitive Disorders
Disentangling primary psychiatric disorders from cancer-related somatic symptoms, medication toxicities, and metabolic derangements is one of the most challenging APRN competencies.
Diagnostic Distinctions
- Major Depressive Disorder (MDD) vs. Cancer-Related Fatigue (CRF):
- Cancer-Related Fatigue: Predominantly physical exhaustion, low energy, and sluggishness. Anhedonia (inability to experience pleasure) and feelings of worthlessness/excessive guilt are absent.
- MDD: Core psychological symptoms of pervasive anhedonia, persistent depressed mood, hopelessness, guilt, worthlessness, and suicidal ideation are present regardless of physical energy levels.
- Adjustment Disorder with Depressed/Anxious Mood:
- Development of emotional or behavioral symptoms in response to an identifiable stressor (e.g., cancer diagnosis) within 3 months of stressor onset. Distress is out of proportion to the severity of the stressor or results in significant functional impairment, but does not meet full DSM-5 criteria for MDD.
- Hypoactive Delirium vs. Severe Depression:
- Hypoactive Delirium: Acute onset, fluctuating course, inattention, altered consciousness, cognitive disorientation, disorganized thinking. Often caused by hypercalcemia, sepsis, opioids, or brain metastases.
- Depression: Insidious onset, stable course, intact attention and orientation, conscious self-awareness.
- Organic & Treatment-Induced Causes of Psychiatric Symptoms:
- Corticosteroids (dexamethasone/prednisone): Can induce steroid psychosis, mania, severe insomnia, or depression.
- Endocrine therapies (tamoxifen, aromatase inhibitors, ADT): Can trigger mood lability and depressive symptoms.
- Metabolic derangements: Hypothyroidism, hypercalcemia, hyponatremia, vitamin B12 deficiency.
5. Interdisciplinary Referral & Psychiatric Crisis Protocols
Following distress screening, the APRN mobilizes appropriate interdisciplinary team members based on the specific problem domains flagged:
- Social Work: Financial toxicity, housing, transportation, community resources, insurance navigation.
- Psycho-Oncology / Clinical Psychology: Psychotherapy (Cognitive Behavioral Therapy [CBT], Acceptance and Commitment Therapy [ACT]), coping strategies, fear of recurrence.
- Psychiatry / Psychiatric Mental Health NP: Psychopharmacologic management of severe depression, anxiety, organic mood disorders, or psychosis.
- Chaplaincy / Spiritual Care: Existential distress, crisis of faith, spiritual distress, end-of-life reconciliation.
APRN Management of Acute Psychiatric Crisis (Suicidality)
- Item 9 on PHQ-9 Positive or Active Suicidal Ideation: Immediately evaluate intent, plan, and means.
- Safety Protocol: Do not leave the patient unattended. Remove potentially lethal items. Conduct a formal suicide risk assessment (e.g., Columbia-Suicide Severity Rating Scale [C-SSRS]).
- Immediate Intervention: Arrange urgent psychiatric consultation or emergency department transfer for involuntary hold/inpatient psychiatric stabilization if high risk/active plan is present.
An oncology nurse practitioner conducts routine psychosocial distress screening for a 52-year-old female returning for her second cycle of adjuvant chemotherapy for Stage II triple-negative breast cancer. The patient completes the NCCN Distress Thermometer (DT) and rates her distress as a 6 out of 10, indicating severe worry about medical bills and persistent crying spells. What is the most appropriate initial action by the APRN?
Initiate a comprehensive clinical evaluation of flagged problem domains and coordinate targeted referrals to social work and psycho-oncology
Reassure the patient that a distress score of 6 is expected during chemotherapy and schedule re-evaluation in 3 months
Immediately prescribe oral lorazepam 1 mg three times daily and defer further psychosocial assessment
Discontinue chemotherapy until the patient's distress score drops below 2 on the Distress Thermometer
When evaluating a 64-year-old male with metastatic castration-resistant prostate cancer who reports severe lack of energy, poor sleep, and low mood, how can the APRN pathognomonically distinguish Major Depressive Disorder (MDD) from Cancer-Related Fatigue (CRF)?
Presence of severe physical exhaustion following minimal exertion
Pervasive anhedonia, feelings of worthlessness, and persistent hopelessness
Elevated serum inflammatory cytokines and microcytic anemia
Impaired performance on the Lawton Instrumental Activities of Daily Living scale
During a routine outpatient visit, a 45-year-old male undergoing treatment for relapsed acute myeloid leukemia completes the PHQ-9 screening form. The APRN notes a total score of 18, with a positive response to Item 9 ('thoughts that you would be better off dead'). Upon direct questioning, the patient states, 'I have a plan to end it all tonight with my leftover pain medications.' What is the mandatory immediate APRN protocol?
Provide the national suicide prevention hotline phone number and allow the patient to return home with family
Schedule an urgent outpatient psychiatry clinic appointment for the following week and reduce pain medication quantities
Initiate immediate suicide safety protocols, maintain continuous 1-on-1 observation, and arrange emergency psychiatric evaluation/inpatient stabilization
Administer single-dose intravenous haloperidol and discharge the patient to the care of their primary oncologist
Sections you finish are checked off in the contents.